9/11 Skin Cancer Claims: VCF Compensation & WTC Health Program Benefits

Who qualifies for 9/11 skin cancer compensation?

Anyone diagnosed with skin cancer following presence in the covered 9/11 areas, at the Pentagon, or in Shanksville, Pennsylvania during the covered periods may qualify for VCF compensation. This includes area workers, residents, students, teachers, first responders, cleanup and recovery workers, volunteers, and surviving family members of those who died from 9/11-related skin cancer.

Free medical care runs through the WTC Health Program, which covers Manhattan south of Houston Street and any block in Brooklyn within 1.5 miles of the former World Trade Center site. Compensation runs through the VCF, which covers Manhattan south of Canal Street plus routes of debris removal.

If you were between Canal and Houston Street, you may still qualify for both. Daily life in Lower Manhattan rarely stopped at Canal Street, and presence can be established with records or sworn affidavits.

Non-melanoma skin cancers (basal cell carcinoma and squamous cell carcinoma) are among the most frequently certified cancers in the 9/11 community, reflecting both their high incidence in the general population and the extensive dust and debris skin contact that responders, cleanup workers, and downtown residents experienced in the weeks and months after September 11th.

What types of skin cancer are covered by the WTC Health Program?

The WTC Health Program certifies three principal categories of skin cancer, each with its own compensation baseline and its own dedicated page:

• Basal cell carcinoma (BCC): the most common skin cancer and the most common cancer of any type in the United States, per American Cancer Society reference data. Arises from the basal cells at the bottom of the epidermis. Rarely metastasizes but can cause significant local tissue damage if untreated. Non-melanoma skin cancer baseline: $90,000.
• Squamous cell carcinoma (SCC): the second most common skin cancer, per American Cancer Society reference data. Arises from the squamous cells in the outer layer of the epidermis. More likely than basal cell to metastasize if untreated, particularly when arising on the lip, ear, or in immunocompromised patients. Non-melanoma skin cancer baseline: $90,000.
• Melanoma: the most serious common skin cancer, accounting for the majority of skin cancer deaths despite being far less common than BCC or SCC. Arises from melanocytes, the pigment-producing cells of the skin. Statutory maximum baseline for a single cancer condition: $250,000.

Rare non-melanoma skin cancers, including Merkel cell carcinoma, dermatofibrosarcoma protuberans, cutaneous T-cell lymphoma (mycosis fungoides), Kaposi sarcoma, and sebaceous carcinoma, are covered under the WTC Health Program's rare-cancer certification framework. These are evaluated case-by-case and are typically compensated at the top of the cancer range given their severity.

More than 400,000 people are estimated to have been exposed to 9/11 toxins in Lower Manhattan alone, with additional exposures at the Pentagon and Shanksville, Pennsylvania. The dust, smoke, and debris released by the collapse of the World Trade Center contained known and suspected carcinogens including asbestos, silica, polycyclic aromatic hydrocarbons, dioxins, furans, heavy metals, and other combustion byproducts. Skin was one of the most directly exposed organs. Dust settled on the face, neck, forearms, and any uncovered surface, and prolonged contact was the norm for responders, cleanup workers, and residents returning to Lower Manhattan.

Skin cancer arises through cumulative damage to skin cell DNA. Ultraviolet radiation is the most well-established environmental cause of skin cancer, but chemical carcinogens, including several of those documented in the 9/11 dust, also contribute. Polycyclic aromatic hydrocarbons and arsenic, both present in the WTC debris field, have long been recognized as chemical carcinogens with a documented association with non-melanoma skin cancer.

Skin cancer does not appear immediately after exposure to a carcinogen. There is typically a period of years between exposure and clinical detection. The WTC Health Program requires a minimum four-year latency period between first 9/11 exposure and first skin cancer diagnosis before certification.

Certification does not require proof that 9/11 exposure was the only cause of a particular skin cancer. Under federal law, the standard is whether the exposure was substantially likely to be a significant factor in aggravating, contributing to, or causing the condition. Fair skin, cumulative sun exposure, prior tanning bed use, family history, and other established skin cancer risk factors are common in the 9/11 community and generally do not prevent certification.

Skin cancer symptoms vary by type. The checklist below covers the most common presentations across basal cell carcinoma, squamous cell carcinoma, and melanoma. Any new, changing, or non-healing skin lesion in a person with 9/11 exposure history should be evaluated by a WTC Health Program participating dermatologist.

Non-melanoma skin cancer signs (basal cell and squamous cell)

• A pearly, waxy, or translucent bump, often with visible blood vessels
• A flat, scaly, reddish or brownish patch that does not heal
• A firm, red nodule
• A sore that heals and then returns, or bleeds without an obvious cause
• Rough, scaly patches (actinic keratoses) that can progress to squamous cell carcinoma
• Any lesion that grows, ulcerates, or crusts over on sun-exposed skin

Melanoma warning signs (ABCDE rule)

• Asymmetry: one half of the mole does not match the other
• Border: irregular, ragged, notched, or blurred edges
• Color: uneven color, including shades of brown, black, tan, red, white, or blue
• Diameter: larger than 6 millimeters (about the size of a pencil eraser), though melanomas can be smaller
• Evolving: any change in size, shape, color, elevation, or new symptoms such as bleeding, itching, or crusting

Screening dermatology examinations are available through the WTC Health Program for enrolled members. Early detection matters most for melanoma, which is highly treatable when caught early but becomes far more dangerous once it spreads.

The WTC Health Program requires a minimum four-year latency period between the first date of 9/11 exposure and first date of skin cancer diagnosis. This latency requirement is set by the WTC Health Program and applies to basal cell carcinoma, squamous cell carcinoma, and melanoma. A skin cancer diagnosed less than four years after first date of exposure cannot be certified as 9/11-related.

Most skin cancer claimants meet the four-year requirement on its face. If the first 9/11 exposure occurred in September 2001 or in the weeks and months following, skin cancers diagnosed from that same date in September 2005 forward satisfy latency. Diagnoses from 2010, 2015, or 2020 are all well past the latency threshold.

The two-year VCF registration deadline runs from the date the WTC Health Program certifies the skin cancer as 9/11-related, not from the date of diagnosis. Registration preserves the right to file a claim; the actual claim filing deadline is October 1, 2090 for all claimants. A skin cancer diagnosed years ago remains eligible for certification.

What is the VCF payout for 9/11 skin cancer?

Certified 9/11 skin cancer qualifies claimants for free medical treatment through the WTC Health Program, and allows the claimant to submit a claim for financial compensation through the September 11th Victim Compensation Fund. The VCF's non-economic loss awards for skin cancer are published in its Non-Economic Loss Awards and Certified Conditions Fact Sheet, and they differ by type.

Non-economic loss awards by skin cancer type

• Non-melanoma skin cancer (basal cell and squamous cell) baseline: $90,000. Basal cell carcinoma and squamous cell carcinoma occupy the lower end of the VCF cancer range under Policies & Procedures Section 2.1, reflecting their generally favorable prognosis and localized treatment. This $90,000 figure applies to a certified BCC or SCC diagnosis on its own record.
• Melanoma baseline: $250,000. Melanoma is compensated at the statutory maximum for a single cancer condition, reflecting its significantly higher mortality and the risk of metastasis.
• Both a certified non-melanoma skin cancer and a certified melanoma: $300,000 combined. Where a claimant has both a certified BCC or SCC and a certified melanoma on the same record, the combined non-economic loss award is $300,000. This is not $90,000 plus $250,000; the VCF weighs severity across certified conditions rather than simply adding baseline amounts.
• Aggregate with other certified conditions. Where a claimant has additional certified conditions beyond skin cancer (for example, an extraordinarily severe certified lung condition alongside multiple certified cancers of different sites), aggregate non-economic loss compensation may reach the current VCF maximum of $340,000. The $340,000 aggregate is reserved for claims involving two or more certified cancers with long-term side effects of the condition or treatment, or a certified cancer alongside another certified non-cancer condition of extraordinary severity.

Multiple non-melanoma skin cancers

Many claimants develop more than one basal cell carcinoma or squamous cell carcinoma over the years. The VCF's non-economic loss framework for non-melanoma skin cancer is condition-based rather than lesion-based, so a claimant with multiple BCC or SCC diagnoses is compensated within the non-melanoma skin cancer framework rather than receiving separate awards for each lesion. Documentation of the full history matters for the medical record and for economic loss, and can support the aggregate framework where it applies. For how a later melanoma diagnosis or additional non-melanoma diagnoses affect an existing claim, see our detailed post on amending an existing skin cancer claim.

Economic loss and wrongful death compensation

In addition to non-economic loss, the VCF may award economic loss for medical expenses, lost earnings, and other financial impacts from skin cancer or skin cancer treatment. These economic loss awards can be significant in melanoma cases involving temporary or permanent disability caused by the effects of the cancer and/or treatment. Wrongful death compensation is available to the personal representatives of individuals who died from 9/11-related skin cancer, most often melanoma. Attorney fees for VCF claims are capped at 10% by federal statute.

How Baione Law handles a 9/11 skin cancer claim

Baione Law represents 9/11 skin cancer claimants at every stage:

1. Free Case Review. The firm evaluates presence in the exposure zone, exposure category, skin cancer diagnosis and type (BCC, SCC, melanoma, or rare skin cancer), and current WTCHP certification status. No cost, no obligation.
2. Our fee is 10%, paid only from your award. If you don't get paid, neither do we. The 10% cap is set by federal statute.
3. WTC Health Program enrollment and certification support. For claimants not yet enrolled, the firm assists with enrollment and coordinates dermatology and pathology record submission to WTCHP medical providers for certification, including for the full history of skin cancer diagnoses.
4. VCF registration and claim filing. The firm registers the claim, files the compensation claim, and prepares supporting documentation including for presence and compensation.
5. Medical records and impact documentation. The firm compiles the applicable medical, economic, and non-economic loss documentation the VCF requires, particularly relevant where a claimant has multiple certified skin cancers or a skin cancer alongside other certified conditions.
6. Award, appeals, and amendments. After the VCF issues an award, the firm reviews it, files an appeal if warranted, and handles amendments for subsequent certified conditions, including any progression to metastatic melanoma or the certification of additional non-melanoma skin cancers.